+44 (0) 1223 737941 enquiries@cn-bio.com
  • Events
  • News
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
  • Events
  • News
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
CN Bio
  • Home
  • CN Bio
    • The Company
    • Management Team
    • Careers
  • Organ-On-Chip
    • About Organ-On-Chip
    • Liver-On-Chip
    • Barrier Models
    • 3D Cell Culture
    • Toxicology
    • Drug Metabolism
    • Disease Modelling
  • Products & Services
    • PhysioMimix™ OOC
      • Product Information
      • Consumables
      • T12
      • LC12
    • Human Cell Referral
    • NASH Fee-For-Service
    • Drug Metabolism and Safety Toxicity Testing Services
  • Resources
    • Scientific Publications
    • Brochures
    • Videos
  • Contact
Select Page

Bloomberg

by CN Bio | Apr 29, 2015 | Media Coverage | 0 comments

bloomberg_logo

Drug Testing, Now without the Chimp:

http://www.bloomberg.com/news/articles/2015-04-29/chimps-give-way-to-chips-as-drug-makers-seek-lower-costs

Recent Posts

  • CN Bio’s PhysioMimix™ technology receives FDA recognition 11th January 2021
  • Life in the Fastlane 11th January 2021
  • CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients 15th December 2020

Categories

  • Business
  • Media Coverage
  • OOC Blog
  • Press releases
  • Uncategorised
← Back To All News
Website built and designed by Website Energizers LTD | © 2021 CN Bio Innovations | Registered No. 06517359 | VAT No. 978184563 | Privacy Policy | Terms | Sitemap
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok